Evidence map›Paper›PMID 25144323›Full record

ArticleNature communications2014

Cardiac arrhythmia induced by genetic silencing of 'funny' (f) channels is rescued by GIRK4 inactivation.

Pietro Mesirca, Jacqueline Alig, Angelo G Torrente, Jana Christina Müller, Laurine Marger, Anne Rollin, Claire Marquilly, Anne Vincent, Stefan Dubel, Isabelle Bidaud and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 81 citations in OpenAlex.

  1. L-Type CaCirculation research · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Depressed HCN4 function in the type 2 diabetic sinoatrial node.Molecular and cellular biochemistry · 2023
    Article
  7. Relevance ofInternational journal of molecular sciences · 2023
    Review
  8. Article
  9. Review
  10. Journal of cardiovascular development and disease · 2023
    Article
  11. Heart rate reduction after genetic ablation of L-type CaFrontiers in cardiovascular medicine · 2023
    Article
  12. Article
  13. Paradigm shift: new concepts for HCN4 function in cardiac pacemaking.Pflugers Archiv : European journal of physiology · 2022
    Review
  14. L-Type CaCells · 2022
    Article
  15. Article
  16. Article
  17. ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2021
    Review
  18. Developmental HCN channelopathy results in decreased neural progenitor proliferation and microcephaly in mice.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Pharmacologic Approach to Sinoatrial Node Dysfunction.Annual review of pharmacology and toxicology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 3 countries.

Pietro Mesirca1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Jacqueline AligExperimental Neuropediatrics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Angelo G Torrente1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Jana Christina MüllerDepartment of Cellular and Integrative Physiology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Laurine Marger1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Anne Rollin1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Claire Marquilly1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Anne Vincent1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Stefan Dubel1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Isabelle Bidaud1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Anne FernandezCentre national de la recherche scientifique, UPR-1142, Institut de Génétique Humaine, F-34094 Montpellier, France.
Anika Seniuk1] Department of Cellular and Integrative Physiology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany [2] Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), University Medical Center Hamburg-Eppendorf, partner site Hamburg/Kiel/Luebeck, Martinistrasse 52, 20246 Hamburg, Germany.
Birgit Engeland1] Experimental Neuropediatrics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany [2] Experimental Neurophysiology, University Hospital Cologne, 50924 Cologne, Germany [3] German Center for Neurodegenerative Diseases (DZNE), 53175, Bonn, Germany.
Jasmin SinghDepartment of Experimental Pharmacology and Toxicology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Lucile MiquerolDevelopmental Biology Institute of Marseille, Université Aix-Marseille, CNRS UMR 7288, 13288 Marseille, France.
Heimo Ehmke1] Department of Cellular and Integrative Physiology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany [2] Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), University Medical Center Hamburg-Eppendorf, partner site Hamburg/Kiel/Luebeck, Martinistrasse 52, 20246 Hamburg, Germany.
Thomas Eschenhagen1] Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), University Medical Center Hamburg-Eppendorf, partner site Hamburg/Kiel/Luebeck, Martinistrasse 52, 20246 Hamburg, Germany [2] Department of Experimental Pharmacology and Toxicology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Joel Nargeot1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France.
Kevin WickmanDepartment of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Dirk Isbrandt1] Experimental Neuropediatrics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany [2] Experimental Neurophysiology, University Hospital Cologne, 50924 Cologne, Germany [3] German Center for Neurodegenerative Diseases (DZNE), 53175, Bonn, Germany [4].
Matteo E Mangoni1] Département de Physiologie, Institut de Génomique Fonctionnelle, LabEx ICST, F-34094 Montpellier, France [2] UMR-5203, Centre national de la recherche scientifique, Universités de Montpellier 1 &2, F-34094 Montpellier, France [3] INSERM U661, Universités de Montpellier 1 &2, F-34094 Montpellier, France [4].
Université de Montpellier · FRUniversity Medical Center Hamburg-Eppendorf · DEInstitut de Génomique Fonctionnelle · FRLaboratoire d'Excellence Canaux Ioniques d'Intérêt Thérapeutique · FRUniversität Hamburg · DECentre National de la Recherche Scientifique · FRGerman Centre for Cardiovascular Research · DEInstitut de Génétique Humaine · FRUniversity of Minnesota · US

Funding

The role of RGS proteins in the parasympathetic control of heart rateR01HL105550 · NHLBI · UNIVERSITY OF MINNESOTA · PI MARTEMYANOV, KIRILL A., WICKMAN, KEVIN D · 2011 to 2018
$3.2M
Modulation of Cav 1.3 L-type Ca2+ channels by PDZ-protein interactionsR01HL087120 · NHLBI · UNIVERSITY OF IOWA · PI LEE, AMY · 2009 to 2012
$1.4M
NHLBI NIH HHS R01 HL087120NHLBI NIH HHS R01HL087120-A2NHLBI NIH HHS R01 HL105550NHLBI NIH HHS R01HL105550
6 · The paper itself

Abstract

The mechanisms underlying cardiac automaticity are still incompletely understood and controversial. Here we report the complete conditional and time-controlled silencing of the 'funny' current (If) by expression of a dominant-negative, non-conductive HCN4-channel subunit (hHCN4-AYA). Heart-specific If silencing caused altered [Ca(2+)]i release and Ca(2+) handling in the sinoatrial node, impaired pacemaker activity and symptoms reminiscent of severe human disease of pacemaking. The effects of If silencing critically depended on the activity of the autonomic nervous system. We were able to rescue the failure of impulse generation and conduction by additional genetic deletion of cardiac muscarinic G-protein-activated (GIRK4) channels in If-deficient mice without impairing heartbeat regulation. Our study establishes the role of f-channels in cardiac automaticity and indicates that arrhythmia related to HCN loss-of-function may be managed by pharmacological or genetic inhibition of GIRK4 channels, thus offering a new therapeutic strategy for the treatment of heart rhythm diseases.

Indexed as

AnimalsArrhythmias, CardiacBenzazepinesCalcium SignalingDisease Models, AnimalFemaleG Protein-Coupled Inwardly-Rectifying Potassium ChannelsHeart RateHumansHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIvabradineMaleMiceMice, Inbred C57BLMice, TransgenicMuscle ProteinsBenzazepinesG Protein-Coupled Inwardly-Rectifying Potassium ChannelsHCN4 protein, humanHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIvabradineKcnj5 protein, mouseMuscle ProteinsPotassium Channels

Identifiers

PMID25144323
PMCPMC4207211
OpenAlexW2014303946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.